FDA Inspection 1193902 — Silgan Unicep Packaging, LLC
The FDA completed an inspection of Silgan Unicep Packaging, LLC on December 1, 2022 in Sandpoint, ID. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 1, 2022
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Sandpoint, ID (United States)